• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

MedCap

551.50 SEK+3.86 %11/8 17:29
Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+3.86 %
+10.19 %
+8.35 %
+10.41 %
+0.46 %
-15.41 %
+80.82 %
+162.62 %
+5,360.40 %

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2001 and is headquartered in Stockholm.

Read more
Market cap
8.32B SEK
Turnover
15.84M SEK
Revenue
2.11B
EBIT %
14.37 %
P/E
37.52
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23/10
2026

Interim report Q3'26

5/2
2027

Annual report '26

29/4
2027

Interim report Q1'27

Press release2026-07-26 17:48

Redeye: MedCap (Q2 Review): Broad-Based Beat

MedCap
Regulatory press release2026-07-21 06:30

Stark tillväxt; justerad EBITA ökade med 28 %

MedCap
Regulatory press release2026-07-21 06:30

Strong growth – adjusted EBITA increased by 28 percent

MedCap

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-26 15:40

MedCap AB (publ) har tecknat avtal om att förvärva Biopsafe ApS i Danmark.

MedCap
Regulatory press release2026-06-26 15:40

MedCap AB (publ) has signed an agreement to acquire Biopsafe ApS in Denmark.

MedCap
Regulatory press release2026-05-29 08:30

Ändring av antal aktier och röster i MedCap AB

MedCap
Regulatory press release2026-05-20 16:30

Återköp av aktier i MedCap 15 maj 2026 - 20 maj 2026 – återköpsprogram avslutat

MedCap
Regulatory press release2026-05-13 14:00

Återköp av aktier i MedCap 7 maj 2026 – 13 maj 2026

MedCap
Regulatory press release2026-05-06 17:30

MedCap beslutar om aktieåterköpsprogram

MedCap
Press release2026-05-05 08:53

Redeye: MedCap (Q1 review): Strong EBITA Growth, Poised for Acquisitions

MedCap
Regulatory press release2026-05-04 17:30

Stämmokommuniké årsstämma 4 maj 2026

MedCap
Regulatory press release2026-04-29 06:30

Strong result; EBITA increased by 30%

MedCap
Regulatory press release2026-04-29 06:30

Starkt resultat; EBITA ökade med 30%

MedCap
Regulatory press release2026-03-30 08:30

KALLELSE ÅRSSTÄMMA I MEDCAP AB (PUBL) DEN 4 MAJ 2026

MedCap
Regulatory press release2026-03-25 15:00

Ledningsförändringar i MedCap AB

MedCap
Regulatory press release2026-03-23 08:30

MedCap publicerar årsredovisning för 2025

MedCap
Press release2026-02-11 13:33

Redeye: MedCap (Q4 review): Beat on Solid Organic Growth

MedCap
Regulatory press release2026-02-09 09:00

Ledningsförändringar i MedCap AB

MedCap
Regulatory press release2026-02-06 06:30

Starkt resultat; EBITA ökade med 68% i kvartalet och 26% för helåret

MedCap
Regulatory press release2026-02-06 06:30

Strong results: EBITA increased by 68% for the quarter and 26% for the full year

MedCap